Is the Risk of Intrahepatic Cholestasis Increased with Supplemental Progesterone?

Matthew C H RohnLindsey VignaliIsabel ReederKiana KhosravianScott Petersen

Published in: American journal of perinatology (2024)

· Supplemental progesterone use in pregnancy may increase the risk of developing ICP.. · Previous investigations of progesterone and ICP have demonstrated mixed results.. · The association may be dependent on the route of administration and formulation of progesterone..

Keyphrases

estrogen receptor
drug delivery
preterm birth
pregnant women
drug induced
pregnancy outcomes